logo

Bristol-Myers Squibb Co. (BMY)



Trade BMY now with
  Date
  Headline
5/3/2018 8:42:25 AM EMA Validates BMY's Type II Application For Opdivo Plus Yervoy Combination For Treatment Of First-Line Metastatic NSCLC
5/2/2018 8:31:14 AM Bristol-Myers Squibb And Flatiron Health Announce Three-year Collaboration Agreement
4/27/2018 7:04:56 AM Advantagene Enters Clinical Trial Collaboration With Bristol-Myers Squibb
4/26/2018 7:10:56 AM Bristol-Myers Squibb Co. (BMY) Has Raised Its 2018 EPS Estimate To 3.35 - 3.45 From 3.15 - 3.30
4/26/2018 6:59:30 AM Bristol-Myers Squibb Q1 GAAP EPS $0.91 And Non-GAAP EPS $0.94
4/18/2018 4:16:56 PM Bristol-Myers Squibb: FDA Accepts For Priority Review Its Supplemental BLA For Opdivo (nivolumab)
4/17/2018 9:04:18 AM William Blair Reiterates Bristol-Myers Squibb Co. (BMY) At Outperform
4/16/2018 4:22:54 PM Bristol-Myers Squibb Announces Collaboration With Janssen On A Factor XIa Inhibitor Program
4/16/2018 9:09:14 AM Bristol-Myers Announces Initial Results From Phase 3 Study, CheckMate -227, Evaluating Opdivo Mg/kg Pluslow-dose Yervoy